Science

Guillain-Barré Syndrome Treatment Breakthrough

Updated 2026-07-30 10:10 UTC 1 source Positive

A new drug has been developed to target the immune system component responsible for Guillain-Barré syndrome, potentially marking a significant step in treating this autoimmune condition.

Coverage timeline — 1 article

New Scientist

First-of-kind Guillain-Barré drug switches off part of immune system

A treatment that turns off the bit of the immune system that goes haywire in Guillain-Barré syndrome may be the first targeted therapy approved for the autoimmune condition

2026-07-30 10:00 UTC